Many COVID-19 vaccine players are in the green premarket in apparent response to a potential safety signal in a Phase 3 study of AstraZeneca’s (NYSE:AZN) AZD1222. AZN is down 2% on light volume.
Selected tickers: Sanofi (NASDAQ:SNY) (+2%), GlaxoSmithKline (NYSE:GSK) (+2%), Pfizer (NYSE:PFE) (+2%), BioNTech SE (NASDAQ:BNTX) (+5%), Moderna (NASDAQ:MRNA) (+5%), Dynavax (NASDAQ:DVAX) (-2%); Novavax (NASDAQ:NVAX) (+7%), iBio (NYSEMKT:IBIO) (+8%), Vaxart (NASDAQ:VXRT) (+4%), Inovio Pharmaceuticals (NASDAQ:INO) (+6%), Heat Biologics (NASDAQ:HTBX) (+4%), CureVac (NASDAQ:CVAC) (+4%)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.